Medtronic Breaks Out On Another 'Clean Beat' And 300% Growth For One Segment

Core Insights - Medtronic reported adjusted earnings of $1.36 per share and $8.96 billion in sales for the third quarter, exceeding analyst expectations of $1.31 earnings per share and $8.87 billion in sales [1] - The company raised its sales growth forecast for the year to 5.5%, up from the previous estimate of 5% [2] - Medtronic's stock rose nearly 4% in premarket trading, indicating positive market sentiment [3] Financial Performance - Adjusted earnings for the previous year were $1.26 per share with sales of $8.4 billion, showing year-over-year growth [1] - The updated earnings guidance for the year is set between $5.62 and $5.66 per share, with the lower end raised by two cents [2] - The total projected sales for the year is now $35.84 billion [2] Market Reaction - Medtronic's stock is forming a flat base with a buy point at $99.37, suggesting potential for a breakout [3] - The stock's recent performance has earned it an 83 RS rating, indicating strong market leadership [6]